Clinical trial trends 2026
Clinical Research in 2026: What Changed — and Why It Matters  Key Takeaways   Clinical research is becoming more selective, not slower.  Capital, regulation, and policy volatility are forcing sharper prioritization and earlier decisions.  Execution quality now carries financial consequences.  Late-stage trials leave little room for operational error, weak endpoints, or slow enrollment.  Risk is moving upstream.  AI, alternative preclinical models, and modular global development are shifting decision-making earlier.  Read more
neurology cro
Neurology CRO: A Practical Guide to Running Successful CNS Clinical Trials Clinical trials in neurology remain among the most complex andhigh-riskin drug development. High placebo response, slow disease progression, subjective endpoints, and patient retention challenges consistently contribute to failure rates that exceed many other therapeutic areas.  This is why sponsors increasingly turn to a neurology CRO — not just a general clinical research organization with CNS experience, but a partner built to Read more
Top 2025 clinical trials
2025’s Top Clinical Trials: Closing a Transformative Year in Medicine 2025 was not a year of merely “positive” trials. It was a year defined by effect sizes, first-line shifts, and disease-modifying signals that are already changing real clinical decision-making. Across oncology, cardiometabolic disease, liver and rare disorders, several late-stage readouts stood out not because they met endpoints, but because they reset expectations — introducing new standards of Read more
Clinical Research Focus. 48th Edition Clinical Research Focus featuring topical articles of interest to the clinical trial community. Explore the news of January 2026. Read more

Schedule a meeting

We are excited to connect with you, understand your goals, and explore how we can support your needs.

Contact us